Oncotropic H-1 parvovirus infection degrades HIF-1α protein in human pancreatic cancer cells independently of VHL and RACK1

International Journal of Oncology
Il-Rae ChoYoung-Hwa Chung

Abstract

Overexpression of HIF-1α, a transcription factor responsive to hypoxia, is frequently observed in malignant tumors, which sometimes show resistance to chemotherapy and radiation therapy. Consequently, decrease of HIF-1α through virotherapy offers a logical strategy for the treatment of aggressive tumors. In this study, we found that infection with the oncolytic H-1 parvovirus decreased HIF-1α protein levels in pancreatic cancer cells under CoCl2 or hypoxia. The H-1 virus-induced decrease of HIF-1α was regulated by a proteasome-mediated pathway. Suppression of VHL, an E3 ligase and a critical regulator of HIF-1α, or enforced expression of UCP, an E2 ubiquitin-conjugating enzyme, failed to inhibit the H-1 virus-induced decrease of HIF-1α. Furthermore, siRNA-mediated suppression of RACK1, another regulator of HIF-1α, did not prevent H-1 viral infection from lowering HIF-1α protein levels. Although decrease of HIF-1α was observed after H-1 viral infection, constitutive expression of HIF-1α limited H-1 viral replication. After combined treatment with H-1 parvovirus and YC-1, an inhibitor of HIF-1α, the apoptosis of pancreatic cancer cells was greater than after treatment with H-1 virus alone or YC-1 alone. Accordingly, we propose th...Continue Reading

References

Oct 1, 1984·Journal of Virology·P R ParadisoR L Costantino
Jan 19, 2000·The American Journal of Gastroenterology·R H HawesJ L Abbruzzese
Feb 22, 2001·Journal of the National Cancer Institute·M Höckel, P Vaupel
Dec 3, 2002·Nature Reviews. Cancer·Nabeel Bardeesy, Ronald A DePinho
Apr 3, 2003·Journal of the National Cancer Institute·Eun-Jin YeoJong-Wan Park
Feb 28, 2004·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Julia I Bárdos, Margaret Ashcroft
Apr 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E Van CutsemD Von Hoff
Jun 1, 2004·Molecular and Cellular Biology·Naohiro WakisakaJoseph S Pagano
Jun 2, 2004·Nature Reviews. Cancer·J Martin Brown, William R Wilson
Jul 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry Q XiongJames L Abbruzzese
Sep 24, 2004·Current Gene Therapy·Jan J CornelisJean Rommelaere
Dec 8, 2004·Cancer Investigation·Howard SafranTeresa Kennedy
Apr 9, 2005·Cancer Gene Therapy·Hideki KasuyaAkimasa Nakao
Aug 22, 2006·Biochemical and Biophysical Research Communications·Chi Keung LauSheung Tat Fan
Nov 28, 2007·Annual Review of Pathology·Anirban Maitra, Ralph H Hruban
Jul 19, 2008·Digestive Surgery·Koert F D KuhlmannJohn G Wesseling
Oct 27, 2009·International Journal of Cancer. Journal International Du Cancer·Sebastian DempeChristiane Dinsart
Feb 19, 2011·Future Virology·Aaron Yun Chen, Jianming Qiu
Jul 1, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Irina KiprianovaJörg R Schlehofer
Nov 30, 2012·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Sujata HalderMavis Agbandje-McKenna

❮ Previous
Next ❯

Citations

Aug 1, 2019·Mini Reviews in Medicinal Chemistry·Sijia XiaoGaoyun Hu
May 3, 2015·The Journal of General Virology·Frédéric MorinetClaude Capron
Jul 29, 2020·Virology Journal·Esther Shuyi Gan, Eng Eong Ooi
Jun 27, 2020·Cancer Cell International·Xiao JinZheng Liu
Feb 7, 2021·Journal of Clinical Medicine·Andres Garcia-SampedroPilar Acedo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis